Cancer Research Donn Young  Jordan
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

Published online first on June 23, 2009
[Cancer Research, 10.1158/0008-5472.CAN-08-4786]
This Article
Right arrow Full Text (Online First [PDF])
Right arrow Supplementary Data
Right arrow All Versions of this Article:
0008-5472.CAN-08-4786v1
69/14/5927    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Lu, Z.-G.
Right arrow Articles by Yoshida, K.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lu, Z.-G.
Right arrow Articles by Yoshida, K.

Molecular Biology, Pathobiology, and Genetics

Protein Kinase C{delta} Activates RelA/p65 and Nuclear Factor-{kappa}B Signaling in Response to Tumor Necrosis Factor-{alpha}

Zheng-Guang Lu , Hanshao Liu , Tomoko Yamaguchi , Yoshio Miki , and Kiyotsugu Yoshida *

Department of Molecular Genetics, Medical Research Institute, Tokyo Medical and Dental University, Tokyo, Japan

* To whom correspondence should be addressed. E-mail: yos.mgen{at}mri.tmd.ac.jp.


   Abstract

Nuclear factor-{kappa}B (NF-{kappa}B) is tightly modulated by I{kappa}B kinases and I{kappa}B{alpha} in the cytoplasm. On stimulation, NF-{kappa}B translocates into the nucleus to initiate transcription; however, regulation of its transcriptional activity remains obscure. Here, we show that protein kinase C (PKC) {delta} controls the main subunit of NF-{kappa}B, RelA/p65. On exposure to tumor necrosis factor-{alpha} (TNF-{alpha}), the expression of RelA/p65 target genes such as I{kappa}B{alpha}, RelB, and p100/p52 is up-regulated in a PKC{delta}-dependent manner. The results also show that PKC{delta} is targeted to the nucleus and forms a complex with RelA/p65 following TNF-{alpha} exposure. Importantly, kinase activity of PKC{delta} is required for RelA/p65 transactivation. In concert with these results, PKC{delta} activates RelA/p65 for its occupancy to target-gene promoters, including I{kappa}B{alpha} and p100/p52. Moreover, functional analyses show that inhibition of PKC{delta} is associated with substantial attenuation of NF-{kappa}B activity in response to TNF-{alpha}. These findings provide evidence that PKC{delta} orchestrates RelA/p65 transactivation, a requisite for NF-{kappa}B signaling pathway in the nucleus. [Cancer Res 2009;69(14):OF1–9]

Key Words: PKC{delta}, RelA/p65, NF-{kappa}B, transactivation, TNF-{alpha}







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2009 by the American Association for Cancer Research.